TR200101647T2 - İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller. - Google Patents

İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.

Info

Publication number
TR200101647T2
TR200101647T2 TR2001/01647T TR200101647T TR200101647T2 TR 200101647 T2 TR200101647 T2 TR 200101647T2 TR 2001/01647 T TR2001/01647 T TR 2001/01647T TR 200101647 T TR200101647 T TR 200101647T TR 200101647 T2 TR200101647 T2 TR 200101647T2
Authority
TR
Turkey
Prior art keywords
sulfonated
reducing agents
purification
solid phase
immunodiagnostic assays
Prior art date
Application number
TR2001/01647T
Other languages
English (en)
Inventor
Maertens Geert
Louwagie Joost
Bosman Alfons
Sablon Erwin
Zrein Maan
Original Assignee
Innogenetics N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200101647(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics N.V. filed Critical Innogenetics N.V.
Publication of TR200101647T2 publication Critical patent/TR200101647T2/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Mevcut bulus, kati faz bagisiklik tahlili (immünoassay) ile ilgili olup, bahsedilen kati faz üzerinde, indirgeyici bir ajanin varliginda, bir antijenden olusmaktadir. Bunun yaninda, mevcut bulus; sistein içeren, rekombinant olarak tanimlanan bir proteini saflastirmak için bir metot ile ilgili olup, asagidaki basamaklarin en az 2, tercihen 3 veya 4'ü ve hatta daha çok da, tercihen tümünden olusmaktadir: (a) bir lisatin rekombinant tasiyici canli hücrelerinden sülfonasyonu veya guanidinyum klorürün varliginda, rekombinant tasiyici canli hücrelerinin belirtilerinin giderek kaybolmasi (lisis), arkasindan da hücre lisatinin sülfonasyonu, (b) tercihen, hücre kalintilarinin uzaklastirilmasindan sonra, bir zvitteryonik deterjan ile muamele, (c) rekombinant proteinin sülfonasyonlu versiyonunun saflastirilmasi veya ardisik olarak gerçeklestirilen zvitteryonik deterjanin uzaklastirilmasi ile, sülfonasyonlu rekombinant proteinin saflastirilmasi olup (DEVAMI VAR)
TR2001/01647T 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller. TR200101647T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98870087 1998-04-17

Publications (1)

Publication Number Publication Date
TR200101647T2 true TR200101647T2 (tr) 2002-06-21

Family

ID=8237028

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2001/01648T TR200101648T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2002/02213T TR200202213T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2001/01647T TR200101647T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.
TR2000/03024T TR200003024T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
TR2001/01648T TR200101648T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2002/02213T TR200202213T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2000/03024T TR200003024T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.

Country Status (22)

Country Link
US (1) US7935490B2 (tr)
EP (2) EP1071955B2 (tr)
JP (2) JP2002512370A (tr)
KR (1) KR20010042807A (tr)
CN (1) CN1305589A (tr)
AT (2) ATE278960T1 (tr)
AU (1) AU751362B2 (tr)
BR (1) BRPI9909678B8 (tr)
CA (2) CA2658218C (tr)
CY (1) CY1108424T1 (tr)
CZ (1) CZ298268B6 (tr)
DE (2) DE69939132D1 (tr)
DK (2) DK1071955T4 (tr)
ES (2) ES2310701T3 (tr)
HK (1) HK1036653A1 (tr)
HU (1) HUP0101719A3 (tr)
IL (1) IL138791A0 (tr)
PL (1) PL343469A1 (tr)
PT (2) PT1471074E (tr)
TR (4) TR200101648T2 (tr)
WO (1) WO1999054735A1 (tr)
ZA (1) ZA200005445B (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1090033E (pt) * 1998-06-24 2005-05-31 Innogenetics Nv Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
WO2002014362A2 (en) * 2000-08-17 2002-02-21 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
MXPA03009632A (es) * 2001-04-24 2004-06-30 Innogenetics Nv Proteinas de la envoltura de vhc glucosiladas en la estructura central.
JP2004108914A (ja) * 2002-09-18 2004-04-08 Kudo Norio コラーゲンの測定方法
WO2004041853A2 (en) * 2002-11-08 2004-05-21 Innogenetics N.V. Hcv vaccine compositions comprising e1 and ns3 peptides
US20050014136A1 (en) * 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
DE602004029707D1 (de) * 2003-10-28 2010-12-02 Advanced Life Science Inst Inc Verfahren zum nachweis von hepatitis-c-virus
WO2008006017A1 (en) * 2006-07-07 2008-01-10 Pall Corporation Use of denaturing agents during affinity capture
CA2693941A1 (en) * 2007-07-16 2009-01-22 Pfizer Inc. Methods of improving a genomic marker index of dairy animals and products
WO2009035560A1 (en) * 2007-09-12 2009-03-19 Pfizer, Inc. Methods of using genetic markers and related epistatic interactions
JP2011501659A (ja) * 2007-10-03 2011-01-13 ファイザー・インク 有角および無角ウシの遺伝子マーカーおよび関連する方法
WO2009085689A2 (en) * 2007-12-17 2009-07-09 Pfizer Inc. Methods of improving genetic profiles of dairy animals and products
JP5476376B2 (ja) * 2008-07-16 2014-04-23 ラジオメーター・メディカル・アー・ペー・エス 高性能固相
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN107110868B (zh) 2014-10-29 2020-08-21 雅培制药有限公司 采用ns3捕获肽的受试者抗hcv抗体检测测定
CN109870581B (zh) * 2017-12-04 2021-05-04 厦门万泰凯瑞生物技术有限公司 一种定量检测HBsAg的试剂盒及方法
CN109678954B (zh) * 2018-12-29 2022-01-07 山东莱博生物科技有限公司 一对能够特异性识别hcv ns3蛋白的单克隆抗体及其应用
CN110988362B (zh) * 2019-12-20 2023-11-14 迈克生物股份有限公司 抗组蛋白抗体测定试剂、试剂盒及其使用方法
CN112225783B (zh) * 2020-09-16 2021-08-31 东莞市朋志生物科技有限公司 Hcv重组抗原及其突变体
CN112285361B (zh) * 2020-09-27 2023-12-05 中国人民解放军空军军医大学 排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂
CN113219169B (zh) * 2021-05-22 2021-12-17 北京金诺百泰生物技术有限公司 生物检测用封闭剂及其制备方法、包被板及应用该包被板的试剂盒

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139526A2 (en) * 1983-10-20 1985-05-02 Warner-Lambert Company An insolubilized stable specific binding protein
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
ES2059601T3 (es) 1988-05-11 1994-11-16 Abbott Lab Un inmunoensayo para la deteccion de anti-hbc en una muestra biologica.
US4923967A (en) * 1988-09-26 1990-05-08 Eli Lilly And Company Purification and refolding of recombinant proteins
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
EP1304335B1 (en) * 1990-04-04 2009-06-10 Novartis Vaccines and Diagnostics, Inc. Hepatitis C virus protease
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
DE69232871T2 (de) * 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
JP3225468B2 (ja) 1992-08-28 2001-11-05 ダイナボット株式会社 抗体測定用試薬
US7157226B1 (en) 1993-04-27 2007-01-02 Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
DE69432475T2 (de) 1993-11-04 2004-03-04 Innogenetics N.V. Von menschlichen t-zellen immunodominante epiropen des virus der c-hepatitis
ATE208481T1 (de) 1994-06-23 2001-11-15 Energy Answers Corp Anlage zur erzeugung von asche enthaltenden produkten und energie aus abfällen
JPH09503396A (ja) * 1994-07-29 1997-04-08 インノジェネティクス・エヌ・ブイ 診断用及び治療用の精製ｃ型肝炎ウイルスエンベロープ蛋白
DE4428705A1 (de) 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
JPH0862219A (ja) 1994-08-19 1996-03-08 Dainabotsuto Kk 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法
DK0804584T3 (da) 1994-10-21 2002-09-23 Innogenetics Nv Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
US5705330A (en) 1995-04-14 1998-01-06 Abbott Laboratories Chemiluminescent immunoassay for antibody detection
US5616460A (en) 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
EP0935662B1 (en) 1996-05-24 2005-11-30 Chiron Corporation Multiple epitope fusion protein
EP0984846B1 (en) * 1997-01-13 2004-11-24 Rodel, Inc. Method of manufacturing a polymeric polishing pad having photolithographically induced surface pattern

Also Published As

Publication number Publication date
EP1071955B1 (en) 2004-10-06
EP1471074B1 (en) 2008-07-16
CA2324970A1 (en) 1999-10-28
AU751362B2 (en) 2002-08-15
CZ20003819A3 (cs) 2001-10-17
HUP0101719A3 (en) 2006-05-29
PL343469A1 (en) 2001-08-13
JP3974620B2 (ja) 2007-09-12
WO1999054735A1 (en) 1999-10-28
AU3817199A (en) 1999-11-08
DK1071955T3 (da) 2005-02-07
TR200101648T2 (tr) 2002-06-21
CA2324970C (en) 2009-06-30
PT1471074E (pt) 2008-10-23
CN1305589A (zh) 2001-07-25
CA2658218C (en) 2014-10-28
IL138791A0 (en) 2001-10-31
DK1471074T3 (da) 2008-11-17
TR200202213T2 (tr) 2002-11-21
ES2310701T3 (es) 2009-01-16
JP2002512370A (ja) 2002-04-23
EP1071955B2 (en) 2009-02-18
ZA200005445B (en) 2003-01-06
DK1071955T4 (da) 2009-06-15
EP1471074A3 (en) 2004-11-10
ES2230851T5 (es) 2009-06-25
TR200003024T2 (tr) 2000-12-21
DE69939132D1 (de) 2008-08-28
KR20010042807A (ko) 2001-05-25
CY1108424T1 (el) 2014-04-09
US20060263854A1 (en) 2006-11-23
BR9909678A (pt) 2000-12-19
ES2230851T3 (es) 2005-05-01
JP2005185285A (ja) 2005-07-14
DE69920895T3 (de) 2009-09-03
ATE401340T1 (de) 2008-08-15
BRPI9909678B8 (pt) 2021-05-25
BR9909678B1 (pt) 2013-11-12
US7935490B2 (en) 2011-05-03
CA2658218A1 (en) 1999-10-28
HK1036653A1 (en) 2002-01-11
PT1071955E (pt) 2005-02-28
DE69920895D1 (de) 2004-11-11
EP1071955A1 (en) 2001-01-31
CZ298268B6 (cs) 2007-08-08
HUP0101719A2 (hu) 2001-09-28
DE69920895T2 (de) 2005-10-13
EP1471074A2 (en) 2004-10-27
ATE278960T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
TR200101647T2 (tr) İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.
BR9908083A (pt) polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção de m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpo monoclonal, e, proteìna de fusão
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
SHIPOLINI et al. The disulphide bridges of phospholipase A2 from bee venom
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
KR910016766A (ko) 비-a형, 비-b형 간염에 대한 항체와 면역 화학적으로 반응하는 펩타이드류
Oguiura et al. Quantification of crotamine, a small basic myotoxin, in South American rattlesnake (Crotalus durissus terrificus) venom by enzyme-linked immunosorbent assay with parallel-lines analysis
NO950977L (no) Nye forgrenede hydrid- og klasepeptider som er effektive ved diagnostisering og påvisning av ikke-A, ikke-B hepatit
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
ATE147410T1 (de) Igm-antikörper gegen protamin
Bogner et al. Thyroid peroxidase/microsomal antibodies are not identical with thyroid cytotoxic antibodies in autoimmune thyroiditis
FI913714A (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
IE870498L (en) Competitive elisa for detection of antibodies
BR0308095A (pt) Teste para anticorpos anti-ingap
HK1050728A1 (en) Compositions and methods for detecting treponema pallidum.
RU98106859A (ru) Новое антитело, соединение с активностью ренина, содержащее новое антитело, и реактив для определения проренина с использованием нового антитела
CA2309838A1 (en) Haptoglobin assay
KR960034420A (ko) 적어도 2개의 c형간염바이러스관련펩티드로 이루어진 다량체항원펩티드
KR960014341A (ko) 톡소플라즈마 곤디의 항원
RU2000129528A (ru) Усовершенствованные иммунодиагностические анализы с использованием восстановителей
YAMAKI et al. Presence of lower temperature-dependent antibody with low avidity to C100-3 (HCV) antigen in voluntary blood donors
Smith et al. Enzymatic Cleavage of Polypeptides
Savitskaia et al. Immunoenzyme technique for detection of natural antibodies to bradykinin in cardiovascular diseases
SVASTI et al. THE PRESENCE OF TWO IgG SUBCLASSES IN WATER-BUFFALO IMMUNO
UA58895A (uk) Тест-система імуноферментна (dia-chlamydia) для виявлення антитіл класів а та g до chlamydia trachomatis у сироватках та плазмі крові людини